Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2417989
Max Phase: Preclinical
Molecular Formula: C15H22N2O6S2
Molecular Weight: 390.48
Molecule Type: Small molecule
Associated Items:
ID: ALA2417989
Max Phase: Preclinical
Molecular Formula: C15H22N2O6S2
Molecular Weight: 390.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CSCCOCCS)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C15H22N2O6S2/c18-9-13(16-14(19)10-25-8-6-23-5-7-24)15(20)11-1-3-12(4-2-11)17(21)22/h1-4,13,15,18,20,24H,5-10H2,(H,16,19)/t13-,15-/m1/s1
Standard InChI Key: KWRNJIKBZOIYEV-UKRRQHHQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 390.48 | Molecular Weight (Monoisotopic): 390.0919 | AlogP: 0.78 | #Rotatable Bonds: 12 |
Polar Surface Area: 121.93 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.97 | CX Basic pKa: | CX LogP: 0.31 | CX LogD: 0.31 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.18 | Np Likeness Score: -0.89 |
1. Berkov-Zrihen Y, Green KD, Labby KJ, Feldman M, Garneau-Tsodikova S, Fridman M.. (2013) Synthesis and evaluation of hetero- and homodimers of ribosome-targeting antibiotics: antimicrobial activity, in vitro inhibition of translation, and drug resistance., 56 (13): [PMID:23786357] [10.1021/jm400707f] |
Source(1):